2-azacyclocarboxamide derivatives
    31.
    发明授权
    2-azacyclocarboxamide derivatives 失效
    2-氮杂环烷酰胺衍生物

    公开(公告)号:US5047541A

    公开(公告)日:1991-09-10

    申请号:US366070

    申请日:1989-06-14

    摘要: Compounds are provided of the following general structure: ##STR1## wherein A is 2-pyrrolidinyl, 2-piperidinyl or 4-thiazolidinyl and R and R.sub.1 are independently selected from hydrogen and methyl. They are useful for providing sedative and antiepileptic activity.

    摘要翻译: 化合物由以下一般结构提供:其中A是2-吡咯烷基,2-哌啶基或4-噻唑烷基,R和R 1独立地选自氢和甲基。 它们可用于提供镇静和抗癫痫活动。

    1,3,4,6,7,11b-Hexahydro-6-phenyl-2H-pyrazino-(2,1-a)isoquinolines, for
anti-histamine or anti-depression treatment
    32.
    发明授权
    1,3,4,6,7,11b-Hexahydro-6-phenyl-2H-pyrazino-(2,1-a)isoquinolines, for anti-histamine or anti-depression treatment 失效
    1,3,4,6,7,11b-六氢-6-苯基-2H-吡嗪并(2,1-a)异喹啉,用于抗组胺或抗抑郁治疗

    公开(公告)号:US4782058A

    公开(公告)日:1988-11-01

    申请号:US129918

    申请日:1987-12-03

    CPC分类号: C07D471/04

    摘要: Novel 1,3,4,6,7,11b-hexahydro-6-phenyl-2H-pyrazino[2,1-a]isoquinolines, including a cis-1,3,4,6,7,11b-hexahydro-9-methoxy-2-methyl-6-phenyl-2H-pyrazino[2,1-a]isoquinoline dihydrochloride and cis-1,3,4,6,7,11b-hexahydro-9-hydroxy-2-methyl-6-phenyl-2H-pyrazino[2,1-a]isoquinoline dihydrobromide; useful as anti-histamine and anti-depressant agents.

    摘要翻译: 新颖的1,3,4,6,7,11b-六氢-6-苯基-2H-吡嗪并[2,1-a]异喹啉,包括顺式-1,3,4,6,7,11b-六氢-9 - 甲氧基-2-甲基-6-苯基-2H-吡嗪并[2,1-a]异喹啉二盐酸盐和顺式-1,3,4,6,7,11b-六氢-9-羟基-2-甲基-6- 苯基-2H-吡嗪并[2,1-a]异喹啉二氢溴酸盐; 可用作抗组胺和抗抑郁剂。

    Use of alpha, alpha-dialkyl adamantylethylamines to treat measles
    36.
    发明授权
    Use of alpha, alpha-dialkyl adamantylethylamines to treat measles 失效
    使用α,α-二烷基金刚烷乙胺治疗麻疹

    公开(公告)号:US4386105A

    公开(公告)日:1983-05-31

    申请号:US350535

    申请日:1982-02-19

    IPC分类号: A61K31/13 A61P17/00 A61P31/12

    CPC分类号: A61K31/13

    摘要: Warm-blooded animals are treated by administering to the animal a dosage, effective to alleviate the symptoms of measles, of a compound of the formula I or its acid salt: ##STR1## wherein R.sub.1 and R.sub.2 are selected from the class consisting of hydrogen and --CH.sub.3 and at least on pharmaceutically acceptable carrier, wherein the compound is 0.01 to 95% by weight of the composition.

    摘要翻译: 通过向动物施用有效缓解麻疹症状的式I或其酸式盐的治疗方法治疗温血动物:其中R1和R2选自下组: 的氢和-CH 3,并且至少在药学上可接受的载体上,其中化合物为组合物重量的0.01至95%。